1.The effects of lipopolysaccharide on proliferation and apoptosis of BESCs through the PI3K/AKT and Wnt/β-catenin signaling pathways
Junsheng DONG ; Zi WANG ; Hanqing LI ; Fangling ZHENG ; Min ZHANG ; Long GUO ; Kangjun LIU ; Luying CUI ; Heng WANG ; Jianji LI
Chinese Journal of Veterinary Science 2025;45(1):100-106
In order to explore the effects of lipopolysaccharide(LPS)on the repair of bovine endo-metrial stromal cells(BESCs)during inflammatory response,BESCs were treated by LPS in this study.Cell apoptosis rate was detected using flow cytometry,cell viability was measured using the CCK-8 assay,cell migration ability was observed using a scratch assay,and the expression of con-nective tissue growth factor(CTGF),transforming growth factor-beta 3(TGF-β3)and vascular endothelial growth factor(VEGF)mRNA was measured using qRT-PCR.Additionally,the expression of key proteins in the PI3K/AKT and Wnt/β-catenin signaling pathways was assessed using Western blot analysis.The results showed that cell viability of BESCs significantly decreased(P<0.01),cell migration ability decreased(P<0.05),apoptosis rate of BESCs increased(P<0.01),CTGF and TGF-β3 mRNA expression levels decreased(P<0.01),while VEGF mRNA ex-pression increased after treatment with LPS(P<0.01).The phosphorylation levels of PI3K,AKT and GSK-3β proteins decreased(P<0.05),as well as the expression levels of c-Myc and Cyclin-D1 proteins also decreased(P<0.01).These results indicated that LPS can inhibit the proliferation of BESCs and promote cell apoptosis possibly through the inhibition of the PI3K/AKT and Wnt/β-catenin signaling pathways.
2.Effects of freeze-drying and dry heat virus inactivation processes on the biological activities of human plasma derived α2-macroglobulin
Teng FENG ; Fangling QI ; Qiang WANG ; Rui WANG ; Shaowei WANG ; Junting JIA ; Chongwei CHEN ; Jingang ZHANG ; Fang YUAN ; Yuyuan MA
Military Medical Sciences 2025;49(1):35-40
Objective To assess the impact of freeze-drying and dry heat virus inactivation processes on the activity ofα2-macroglobulin(A2M)derived from human plasma Cohn fraction Ⅳ.Methods A2M derived from human plasma Cohn fraction Ⅳ was prepared and subjected to programmed freeze-drying with dry heat virus inactivation.The lyophilized products were evaluated for their appearance,water content,and validation of the viral inactivation process.The bioactivity of the products before and after lyophilization as well as before and after dry heat inactivation was determined via trypsin inhibition,and the comparisons were studied.Results The appearance of the lyophilized product was fluffy,and the water content was(5.83±0.45)%.The specific activities of the samples before and after lyophilization were(10.199±0.137)and(10.033±0.201)μg/mg,respectively,with no statistically significantdifference between the two groups(P>0.05).The viral inactivation of the samples was carried out by using dry heat inactivation conditions at 100 ℃ for 30 min.After inactivation,the reduction was ≥5.125 LgTCID50/0.1 mL in Pseudorabies virus(PRV)titers,≥4.500 LgTCID50/0.1 mL in Sindbis virus(SinV)titers,≥6.375 LgTCID50/0.1 mL in encephalomyocarditis virus(EMCV)titers,and≥4.500 LgTCID50/0.1 mL in porcine parvovirus(PPV)titers.The specific activities of the samples before and after dry heat were(9.921±0.292)and(10.091±0.278)μ g/mg,respectively,with no statistically significant difference between the two groups.Conclusion A2M derived from human plasma Cohn fraction Ⅳ,when subjected to freeze-drying followed by dry heat inactivation at 100 ℃ for 30 minutes,can effectively inactivate viruses without altering the biological activity of the product.
3.Dexmedetomidine alleviates nerve injury induced by propofol in neonatal rats
Fangling ZHANG ; Yuanfang ZHANG ; Li ZHANG
Basic & Clinical Medicine 2025;45(5):644-650
Objective To investigate the effect of dexmedetomidine(Dex)on propofol-induced nerve injury in neo-natal rats.Methods The rats were divided into control group,intra-peritoneally injected propofol to construct nerve injury model group(50 mg/kg),Low,medium and high dose dexmedetomidine intervention model groups(Dex-L,Dex-M and Dex-H with femoral vein injection of 0.25,0.5 and 1 μg/kg Dex,respectively),and Dex-H+anti-BDNF(10 0μg/kg)group,with 12 animals in each group.The neurological deficit score,number of platform jumping errors,and changes in brain index were detected in rats.HE staining microscopy was applied to measure pathology in the hippocampal CA1 region.ELISA was applied to detect level of interleukin-6(IL-6),monocyte chemotactic protein-1(MCP-1)and tumor necrosis factor-α(TNF-α)in the hippocampal CA1 region.TUNEL staining microscopy was used to measure neuronal apoptosis in the hippocampal CA1 region.Western blot was ap-plied to measure the cleaved caspase-3,proBDNF,mature brain-derived neurotrophic factor(mBDNF),phospho-rylated tyrosine kinase B(p-TrkB),and phosphorylated phosphatidylinositol 3 kinase(p-PI3K)proteins in the hippocampal CA1 region.Results Compared with model group,the neuronal damage in rats was improved in Dex-L group,Dex-M group,and Dex-H group,the neurological deficit score,number of platform jumping errors,brain index,level of IL-6,MCP-1,TNF-α in hippocampal CA1 region,neuronal apoptosis rate,and level of cleaved caspase-3 and pro BDNF proteins all reduced,mBDNF,p-TrkB,and p-PI3K proteins in the hippocampal CA1 re-gion raised(P<0.05).Anti-BDNF inhibited the effect of 1 μg/kg Dex pretreatment on propofol induced nerve inju-ry in neonatal rats.Conclusions Dex pretreatment inhibits neuro-inflammation and neuronal apoptosis,thereby re-duces propofol induced nerve injury in neonatal rats.Its mechanism may be related to the activation of the mBDNF/TrkB/PI3K pathway.
4.Clinicopathological and molecular genetic heterogeneity of diffuse gliomas with the features of polymorphous low-grade neuroepithelial tumor of the young
Xiaoli SU ; Jiawen WU ; Pingling WANG ; Liwen HU ; Yupeng CHEN ; Caihong REN ; Fangling SONG ; Hangrui LIN ; Sheng ZHANG ; Xingfu WANG
Chinese Journal of Pathology 2025;54(11):1163-1171
Objective:To investigate the clinicopathological and molecular genetic characteristics of diffuse gliomas with the features of polymorphous low-grade neuroepithelial tumor of the young (PLNTY) and their prognostic values.Methods:A retrospective analysis was performed on 14 cases of diffuse gliomas with PLNTY features diagnosed at the First Affiliated Hospital of Fujian Medical University, Fuzhou, China from June 2020 to August 2024. Their clinicopathological characteristics were examined, and their molecular genetic and epigenetic features were assessed using next-generation sequencing (NGS) and methylation analysis. Factors influencing prognosis were also analyzed.Results:Among the 14 patients, there were 8 males and 6 females, aged 3-62 years, median 29 (9, 50) years. All cases were initially diagnosed as low-grade diffuse gliomas histologically but exhibited the histological and immunohistochemical features of PLNTY. At the molecular level, all cases showed molecular abnormalities involving the mitogen-activated protein kinase pathway, including 5 cases with FGFR3-TACC3 (F3T3) fusion, 3 cases with FGFR2 fusion, 5 cases with BRAF V600E mutation, and 1 case with FGFR1 mutation. Among them, TERT promoter mutations were frequently observed in tumors with F3T3 fusion (5/5), while NCOR2 in-frame insertion mutations were prominent in tumors with non-F3T3 fusions. Clinical follow-up showed recurrence in 3 cases, all of which had F3T3 fusion and concurrent TERT promoter mutations. Prognostic analysis confirmed that F3T3 fusion with concurrent TERT promoter mutation was associated with poor prognosis.Conclusions:Diffuse gliomas with PLNTY features exhibit heterogeneity in clinicopathology and molecular genetics, with FGFR3/FGFR2 fusions and BRAF/FGFR1 mutations as the most common molecular alteration. They often have concurrent F3T3 fusion and TERT promoter mutations, which are related to poor prognosis. The possibility of molecular glioblastoma should be considered for these tumors. It is thus recommended to perform genetic testing on diffuse gliomas with PLNTY features in order to facilitate integrated diagnosis and provide molecular evidence for accurate evaluation of prognoses.
5.The effects of lipopolysaccharide on proliferation and apoptosis of BESCs through the PI3K/AKT and Wnt/β-catenin signaling pathways
Junsheng DONG ; Zi WANG ; Hanqing LI ; Fangling ZHENG ; Min ZHANG ; Long GUO ; Kangjun LIU ; Luying CUI ; Heng WANG ; Jianji LI
Chinese Journal of Veterinary Science 2025;45(1):100-106
In order to explore the effects of lipopolysaccharide(LPS)on the repair of bovine endo-metrial stromal cells(BESCs)during inflammatory response,BESCs were treated by LPS in this study.Cell apoptosis rate was detected using flow cytometry,cell viability was measured using the CCK-8 assay,cell migration ability was observed using a scratch assay,and the expression of con-nective tissue growth factor(CTGF),transforming growth factor-beta 3(TGF-β3)and vascular endothelial growth factor(VEGF)mRNA was measured using qRT-PCR.Additionally,the expression of key proteins in the PI3K/AKT and Wnt/β-catenin signaling pathways was assessed using Western blot analysis.The results showed that cell viability of BESCs significantly decreased(P<0.01),cell migration ability decreased(P<0.05),apoptosis rate of BESCs increased(P<0.01),CTGF and TGF-β3 mRNA expression levels decreased(P<0.01),while VEGF mRNA ex-pression increased after treatment with LPS(P<0.01).The phosphorylation levels of PI3K,AKT and GSK-3β proteins decreased(P<0.05),as well as the expression levels of c-Myc and Cyclin-D1 proteins also decreased(P<0.01).These results indicated that LPS can inhibit the proliferation of BESCs and promote cell apoptosis possibly through the inhibition of the PI3K/AKT and Wnt/β-catenin signaling pathways.
6.Clinicopathological and molecular genetic heterogeneity of diffuse gliomas with the features of polymorphous low-grade neuroepithelial tumor of the young
Xiaoli SU ; Jiawen WU ; Pingling WANG ; Liwen HU ; Yupeng CHEN ; Caihong REN ; Fangling SONG ; Hangrui LIN ; Sheng ZHANG ; Xingfu WANG
Chinese Journal of Pathology 2025;54(11):1163-1171
Objective:To investigate the clinicopathological and molecular genetic characteristics of diffuse gliomas with the features of polymorphous low-grade neuroepithelial tumor of the young (PLNTY) and their prognostic values.Methods:A retrospective analysis was performed on 14 cases of diffuse gliomas with PLNTY features diagnosed at the First Affiliated Hospital of Fujian Medical University, Fuzhou, China from June 2020 to August 2024. Their clinicopathological characteristics were examined, and their molecular genetic and epigenetic features were assessed using next-generation sequencing (NGS) and methylation analysis. Factors influencing prognosis were also analyzed.Results:Among the 14 patients, there were 8 males and 6 females, aged 3-62 years, median 29 (9, 50) years. All cases were initially diagnosed as low-grade diffuse gliomas histologically but exhibited the histological and immunohistochemical features of PLNTY. At the molecular level, all cases showed molecular abnormalities involving the mitogen-activated protein kinase pathway, including 5 cases with FGFR3-TACC3 (F3T3) fusion, 3 cases with FGFR2 fusion, 5 cases with BRAF V600E mutation, and 1 case with FGFR1 mutation. Among them, TERT promoter mutations were frequently observed in tumors with F3T3 fusion (5/5), while NCOR2 in-frame insertion mutations were prominent in tumors with non-F3T3 fusions. Clinical follow-up showed recurrence in 3 cases, all of which had F3T3 fusion and concurrent TERT promoter mutations. Prognostic analysis confirmed that F3T3 fusion with concurrent TERT promoter mutation was associated with poor prognosis.Conclusions:Diffuse gliomas with PLNTY features exhibit heterogeneity in clinicopathology and molecular genetics, with FGFR3/FGFR2 fusions and BRAF/FGFR1 mutations as the most common molecular alteration. They often have concurrent F3T3 fusion and TERT promoter mutations, which are related to poor prognosis. The possibility of molecular glioblastoma should be considered for these tumors. It is thus recommended to perform genetic testing on diffuse gliomas with PLNTY features in order to facilitate integrated diagnosis and provide molecular evidence for accurate evaluation of prognoses.
7.Clinical Effect of Fangfeng Tongshengsan on Post-chemoembolization Syndrome with Primary Liver Cancer or Postoperative Liver Metastases of Colorectal Cancer
Lin YANG ; Fangling LIU ; Yan WU ; Guowang YANG ; Qi FU ; Qingsheng FAN ; Qing ZHANG ; Xiaomin WANG
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(15):103-109
ObjectiveTo observe the effect of the Fangfeng Tongshengsan on post-chemoembolization syndrome with primary liver cancer or postoperative liver metastases of colorectal cancer. MethodSeventy-two patients suffered from post-chemoembolization syndrome after transcatheter hepatic arterial chemoembolization were randomly divided into 2 groups, including a Fangfeng Tongshengsan group and a control group, with 36 patients in each group. The patients in Fangfeng Tongshengsan group orally took the decoction for consecutive 7 d. The patients in the control group were physically cooled down with alcohol rub bath and ice pack for consecutive 7 d. Furthermore, the difference of fever, Karnofsky performance status (KPS), pain in the liver region, nausea vomiting, constipation, and liver function between these two groups were observed. ResultCompared with the control group, Fangfeng Tongshengsan significantly relieved fever, reduced the body temperature (P<0.05), and shortened the duration of fever (P<0.05), indicating that Fangfeng Tongshengsan remarkably improved the KPS (P<0.05). Meanwhile, Fangfeng Tongshengsan obviously alleviated nausea, vomiting, and constipation status and shortened the duration time compared with the control group (P<0.05). In addition, the parameters of liver function including alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyl transpeptidase (GGT), and total bilirubin (TBIL) were significantly decreased in the Fangfeng Tongshengsan group (P<0.05), which indicated that Fangfeng Tongshengsan alleviated liver dysfunction of patients with post-chemoembolization syndrome. ConclusionFangfeng Tongshengsan can be used to treat post-chemoembolization syndrome with primary liver cancer and postoperative liver metastases of colorectal cancer.
8.Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis.
Yuyi XU ; Ming ZHAO ; Jinxue CAO ; Ting FANG ; Jian ZHANG ; Yanli ZHEN ; Fangling WU ; Xiaohui YU ; Yaming LIU ; Ji LI ; Dongkai WANG
Acta Pharmaceutica Sinica B 2023;13(11):4417-4441
Rheumatoid arthritis is a chronic, systemic autoimmune disease predominantly based on joint lesions with an extremely high disability and deformity rate. Several drugs have been used for the treatment of rheumatoid arthritis, but their use is limited by suboptimal bioavailability, serious adverse effects, and nonnegligible first-pass effects. In contrast, transdermal drug delivery systems (TDDSs) can avoid these drawbacks and improve patient compliance, making them a promising option for the treatment of rheumatoid arthritis (RA). Of course, TDDSs also face unique challenges, as the physiological barrier of the skin makes drug delivery somewhat limited. To overcome this barrier and maximize drug delivery efficiency, TDDSs have evolved in terms of the principle of transdermal facilitation and transdermal facilitation technology, and different generations of TDDSs have been derived, which have significantly improved transdermal efficiency and even achieved individualized controlled drug delivery. In this review, we summarize the different generations of transdermal drug delivery systems, the corresponding transdermal strategies, and their applications in the treatment of RA.
9.Extraction of exosome by gel electrophoresis microfluidic chip and determination of miRNA-21 in exosome of human plasma.
Dan LUO ; Fengying RAN ; Lun WU ; Juan ZHANG ; Fangling REN ; Jingjian LIU ; Binqiang ZHANG ; Qinhua CHEN
Chinese Journal of Biotechnology 2021;37(2):663-672
We developed a high-efficiency microfluidic chip for extracting exosomes from human plasma. We collected peripheral blood from normal human, designed and fabricated a microfluidic chip based on nanoporous membrane and agarose gel electrophoresis to isolate exosomes. The extracted exosomes were characterized by transmission electron microscopy, nanosight and Western blotting, the morphology, concentration and particle size of exosomes were identified and analyzed. Meanwhile, we used ultracentrifugation and microfluidic chip to isolate exosomes separately. The particle size and concentration of the exosomes extracted by two methods were compared and analyzed, and their respective extraction efficiency was discussed. Finally, the expression level of miRNA-21 in exosomes was analyzed by RT-PCR. The microfluidic chip isolated (in 1 hour) high-purity exosomes with size ranging from 30-200 nm directly from human plasma, allowing downstream exosomal miRNA analysis. By comparing with ultracentrifugation, the isolation yield of microfluidic chip was 3.80 times higher than ultracentrifugation when the volume of plasma sample less than 100 μL. The optimized parameters for exosome isolation by gel electrophoresis microfluidic chip were: voltage: 100 V; concentration of agarose gel: 1.0%; flow rate of injection pump: 0.1 mL/h. The gel electrophoresis microfluidic chips could rapidly and efficiently isolate the exosomes, showing great potential in the research of exosomes and cancer biomarkers.
Exosomes
;
Humans
;
MicroRNAs/genetics*
;
Microfluidics
;
Plasma
;
Ultracentrifugation
10.Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis
Qian HUANG ; Yupeng CHEN ; Fangling SONG ; Limei ZHENG ; Xueyong LIU ; Sheng ZHANG ; Xingfu WANG
Chinese Journal of Pathology 2021;50(8):870-875
Objective:To investigate the clinicopathological features of central nervous system (CNS) mesenchymal chondrosarcoma (MCS).Methods:Nine cases of CNS MCS were collected at the First Affiliated Hospital of Fujian Medical University from September 2010 to September 2020. The clinical,imaging,histopathological and immunohistochemical features were reviewed. NCOA2 gene rearrangement was evaluated by fluorescence in situ hybridization (FISH).Results:There were three male and six female patients, with age range of 1 to 59 years (median 31 years). Six cases were intracranial and three cases were intraspinal, and the tumors showed dural attachment. They were often diagnosed as meningioma basing on preoperative imaging. Microscopically, the tumors showed a characteristic biphasic histologic pattern composed of undifferentiated mesenchymal small cells and well-differentiated hyaline cartilage islands. The small cells area were positive for SOX9 (9/9), CD99 (8/9), and without BRG1 and INI1 deletion. The cartilaginous component expressed SOX9 (9/9) and S-100 protein (8/9). NCOA2 gene break apart signal was identified in five cases (5/5). Eight patients were followed up for 4-124 months. Three patients (3/8) had recurrences within one year and two patients died of the tumor.Conclusions:CNS MCS is an extremely rare malignant neoplasm with a propensity to dural involvement. Preoperative imaging has low diagnostic accuracy. CNS MCS should be differentiated from other CNS small round cell tumors and chondrosarcoma. FISH detection of NCOA2 gene rearrangement will assist the diagnosis of MCS.

Result Analysis
Print
Save
E-mail